SCHEMBL24314219

SCHEMBL24314219

N#Cc1ccc2cc(C(=O)NS(=O)(=O)c3ccccc3-c3ccccc3)oc2c1

nearest known ligand 0.42

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ BCAT1 P54687 3/20 0.42
▸ PTGER4 P35408 1/20 0.39
▸ CCR2 P41597 1/20 0.39
▸ FBP1 P09467 1/20 0.38
▸ PTGES O14684 1/20 0.38
▸ KAT6A Q92794 2/20 0.38
▸ MMP2 P08253 1/20 0.38
▸ HPGD P15428 2/20 0.37
▸ KDM4E B2RXH2 1/20 0.37
▸ MEN1 O00255 1/20 0.37
▸ ALDH1A1 P00352 1/20 0.37
▸ POLB P06746 1/20 0.37
▸ GAA P10253 1/20 0.37
▸ KMT2A Q03164 1/20 0.37
▸ SMN1; SMN2 Q16637 2/20 0.37
▸ NPC1 O15118 2/20 0.37
▸ DRD3 P35462 1/20 0.37
▸ KCNH2 Q12809 1/20 0.37
▸ TP53 P04637 1/20 0.37
▸ PKM P14618 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL31723071 1.00 BCAT1 (0.42) BCAT1PTGER4CCR2FBP1PTGES
SCHEMBL31336123 0.85 KAT6A (0.43) BCAT1CCR2KAT6AMEN1KMT2A
SCHEMBL22588427 0.85 BCAT1 (0.43) BCAT1PTGER4FBP1MMP2HPGD
SCHEMBL30538408 0.84 BCAT1 (0.55) BCAT1MMP2HPGDKDM4EMEN1
SCHEMBL31723074 0.84 KDM4E (0.51) BCAT1PTGER4FBP1HPGDKDM4E
SCHEMBL24313791 0.84 KDM4E (0.51) BCAT1PTGER4FBP1HPGDKDM4E
SCHEMBL24313562 0.84 NPC1 (0.46) BCAT1PTGER4FBP1MMP2HPGD
SCHEMBL22588433 0.84 BCAT1 (0.48) BCAT1PTGER4FBP1MMP2HPGD
SCHEMBL22587808 0.82 PTGER4 (0.46) BCAT1PTGER4MMP2HPGDKDM4E
SCHEMBL24313971 0.81 ALDH1A1 (0.41) BCAT1PTGER4FBP1MMP2HPGD

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2022081842-A1 SUBSTITUTED ACYL SULFONAMIDES FOR TREATING CANCER THE BROAD INSTITUTE, INC. (US) 2022-04-21 — — WO disclosed
Send feedback